The Ribosomal Protein uL22 Modulates the Shape of the Protein Exit Tunnel

dc.contributor.authorWekselman, Itai
dc.contributor.authorZimmerman, Ella
dc.contributor.authorDavidovich, Chen
dc.contributor.authorLindahl, Lasse
dc.contributor.authorZengel, Janice M.
dc.contributor.authorYonath, Ada
dc.date.accessioned2019-06-20T19:06:37Z
dc.date.available2019-06-20T19:06:37Z
dc.date.issued2017-08-01
dc.description.abstractErythromycin is a clinically useful antibiotic that binds to an rRNA pocket in the ribosomal exit tunnel. Commonly, resistance to erythromycin is acquired by alterations of rRNA nucleotides that interact with the drug. Mutations in the β hairpin of ribosomal protein uL22, which is rather distal to the erythromycin binding site, also generate resistance to the antibiotic. We have determined the crystal structure of the large ribosomal subunit from Deinococcus radiodurans with a three amino acid insertion within the β hairpin of uL22 that renders resistance to erythromycin. The structure reveals a shift of the β hairpin of the mutated uL22 toward the interior of the exit tunnel, triggering a cascade of structural alterations of rRNA nucleotides that propagate to the erythromycin binding pocket. Our findings support recent studies showing that the interactions between uL22 and specific sequences within nascent chains trigger conformational rearrangements in the exit tunnel.en
dc.description.sponsorshipFunds were provided to A.Y. by the European Research Council (grant 322581-NOVRIB), the Merieux Research grant and the Kimmelman Center for Macromolecular Assemblies. A.Y. holds the Martin and Helen Kimmel Professional chair. M.K was supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities. G.F. is the Incumbent of the David and Stacey Cynamon Research fellow Chair in Genetics and Personalized Medicine. J.Z. and L.L. were supported by grant MCB 0349943 from the National Science Foundation. J.K. is supported by the Bent Thorberg Foundation.en
dc.description.urihttps://www.cell.com/structure/fulltext/S0969-2126(17)30184-3en
dc.format.extent13 pagesen
dc.genrejournal articlesen
dc.identifierdoi:10.13016/m26sr4-mufj
dc.identifier.citationItai Wekselman, et.al, The Ribosomal Protein uL22 Modulates the Shape of the Protein Exit Tunnel, VOLUME 25, ISSUE 8, P1233-1241.E3, AUGUST, DOI: https://doi.org/10.1016/j.str.2017.06.004en
dc.identifier.urihttp://hdl.handle.net/11603/14281
dc.language.isoenen
dc.publisherCell Pressen
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC Biological Sciences Department Collection
dc.relation.ispartofUMBC Faculty Collection
dc.rightsThis item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
dc.subjectribosomesen
dc.subjectantibioticsen
dc.subjecttunnelen
dc.subjectribosomal protein uL22en
dc.subjectresistanceen
dc.subjecterythromycinen
dc.subjectmacrolidesen
dc.titleThe Ribosomal Protein uL22 Modulates the Shape of the Protein Exit Tunnelen
dc.typeTexten

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.56 KB
Format:
Item-specific license agreed upon to submission
Description: